Breaking News on Pharmaceutical Technology

FDA: drug safety benefits of import inspection system easy to Predict

09-Feb-2010 - The US FDA says its new screening system will expedite the importation of genuine drugs...

Almost half of antimalarials in Senegal are substandard; study

09-Feb-2010 - Almost half of antimalarials in Senegal are substandard, according to a USP study which will...

EU revives GMP for excipients

08-Feb-2010 - The EFCG has welcomed the addition of excipient GMP requirements to the draft amendments of...

Actavis to boost tablet capacity; and looking at Ratiopharm

08-Feb-2010 - Icelandic generics firm Actavis says expansion of its tablet plant will boost production capacity 50...

ISCO stem cell production site passes building inspection

08-Feb-2010 - ISCO’s stem cell manufacturing facility has passed final building inspection, enabling it to implement the...

News in brief

Suzhou Eyre cleared for penicillin production by SFDA

02-Feb-2010 - Suzhou Erye Pharmaceutical has received SFDA approval to make penicillin at its new manufacturing facility...

Lonza hit by lower demand last year; cuts capex in 2010

28-Jan-2010 - Full-year income at the Lonza was hit by falling demand for life science ingredients and...

Environmental sustainability should be built into GMP; MPA

27-Jan-2010 - Environmental certification of production facilities should be introduced to GMP legislation and sustainability risk assessments...

Merck KGaA to expand inorganic salts capacity 50%

27-Jan-2010 - Merck KGaA has begun work on a new inorganic salts plant in Darmstadt, Germany, citing...

Nanotech safety bill introduced to US Senate

25-Jan-2010 - Nanotechnology safety legislation designed to address potential health and safety risks posed by the technology...

Freezer-farm phase of PCT’s cell-therapy plant complete

25-Jan-2010 - Work on “freezer farm” phase of Progenitor Cell Therapy’s (PCTs) new manufacturing facility in Allendale,...

AMRI plant gains SafeBridge HPAPI certification

21-Jan-2010 - AMRI’s plant in Rensselaer, New York gained SafeBridge potent compound certification this week after an...

Lupin's Mandideep plant OKed by US FDA

21-Jan-2010 - Indian drugmaker Lupin can start seeking US approval for new drugs made at its API...

Lonza to close Riverside API plant

14-Jan-2010 - Lonza will shut down its API plant in Riverside, Pennsylvania, US by the end of...

Novavax scales up RSV-F vaccine

13-Jan-2010 - Novavax has completed cGMP scale up of its RSV-F vaccine candidate, with the material being...

News in brief

API production starts at Evonik's new plant

11-Jan-2010 - Production has begun at the US API plant German chemicals firm Evonik Industries recently bought...

Insect cells could cut vaccine production to 10 weeks

11-Jan-2010 - Vaccines could be produced in less than 10 weeks from first isolation of the RNA...

GSK to shift Avodart production to Poland in 2011

11-Jan-2010 - GSK says it will start making its BPH drug Avodart (dutasteride) at its facility in...

News in brief

CyDex awarded additional Captisol patent

06-Jan-2010 - The US PTO has granted CyDex new patent for the production of ultra high-purity modified...

DMV-Fonterra builds pharma lactose biz with Domo deal

05-Jan-2010 - Ownership of FrieslandCampina Domo’s pharmaceutical lactose business will be transferred to DMV-Fonterra Excipients, the 50/50...

Marksans cleared to hive off API division

04-Jan-2010 - Marksans Pharma will sell or lease its API manufacturing plants in Pune, India in a...

MedImmune recalls sub-potent FluMist H1N1 vacc in US

23-Dec-2009 - MedImmune has recalled unused doses of its intranasal H1N1 vaccine FluMist in the US after...

Merck & Co to buy Avecia Biologics

21-Dec-2009 - US drug major Merck & Co will buy into the UK's contract biologics manufacturing sector...

Hospira to buy injectables biz from India’s Orchid

21-Dec-2009 - Hospira will pay India’s Orchid Chemicals and Pharmaceuticals approximately $400m (€278m) for its generic injectables...